Literature DB >> 12096208

P-selectin upregulation in bleomycin induced lung injury in rats: effect of N-acetyl-L-cysteine.

A Serrano-Mollar1, D Closa, J Cortijo, E J Morcillo, N Prats, M Gironella, J Panés, J Roselló-Catafau, O Bulbena.   

Abstract

BACKGROUND: A number of adhesion molecules are involved in the process of neutrophil infiltration into the lung. P-selectin is one of these neutrophil-endothelial cell adhesion molecules. A study was undertaken to examine the involvement of P-selectin in the development of bleomycin induced inflammation and the ability of N-acetyl-L-cysteine to reduce the potential expression of this selectin in rats.
METHODS: N-acetyl-L-cysteine (3 mmol/kg po) was administered daily for seven days prior to bleomycin administration (2.5 U/kg). The kinetics of P-selectin expression and the effect of N-acetyl-L-cysteine after bleomycin treatment were measured using radiolabelled antibodies. P-selectin localisation was evaluated by immunohistochemistry and neutrophil infiltration was assessed by myeloperoxidase activity.
RESULTS: Bleomycin administration resulted in an upregulation of P-selectin at 1 hour, returning to baseline at 3 hours. Myeloperoxidase activity showed a significant increase at 6 hours after bleomycin administration that lasted for 3 days. N-acetyl-L-cysteine treatment completely prevented these increases.
CONCLUSION: Upregulation of P-selectin in the lung is associated with neutrophil recruitment in response to bleomycin. The beneficial effect of N-acetyl-L-cysteine on bleomycin induced lung injury may be explained in part by the prevention of neutrophil recruitment in the inflammatory stage of the disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12096208      PMCID: PMC1746384          DOI: 10.1136/thorax.57.7.629

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  33 in total

Review 1.  Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention.

Authors:  J Panés; M Perry; D N Granger
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

2.  The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid.

Authors:  J F WOESSNER
Journal:  Arch Biochem Biophys       Date:  1961-05       Impact factor: 4.013

3.  Role of E-selectin in bleomycin induced lung fibrosis in mice.

Authors:  A Azuma; S Takahashi; M Nose; K Araki; M Araki; T Takahashi; M Hirose; H Kawashima; M Miyasaka; S Kudoh
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

4.  Differing patterns of P-selectin expression in lung injury.

Authors:  N M Bless; S J Tojo; H Kawarai; Y Natsume; A B Lentsch; V A Padgaonkar; B J Czermak; H Schmal; H P Friedl; P A Ward
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

5.  Role of P-selectin and ICAM-1 in pancreatitis-induced lung inflammation in rats: significance of oxidative stress.

Authors:  E Folch; A Salas; J Panés; E Gelpí; J Roselló-Catafau; D C Anderson; S Navarro; J M Piqué; L Fernández-Cruz; D Closa
Journal:  Ann Surg       Date:  1999-12       Impact factor: 12.969

6.  Leukotriene generation and neutrophil infiltration after experimental acute pancreatitis.

Authors:  E Folch; D Closa; N Prats; E Gelpí; J Roselló-Catafau
Journal:  Inflammation       Date:  1998-02       Impact factor: 4.092

7.  Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice.

Authors:  G Gurujeyalakshmi; Y Wang; S N Giri
Journal:  J Pharmacol Exp Ther       Date:  2000-04       Impact factor: 4.030

8.  Molecular mechanisms of neutrophil-endothelial cell adhesion induced by redox imbalance.

Authors:  S Kokura; R E Wolf; T Yoshikawa; D N Granger; T Y Aw
Journal:  Circ Res       Date:  1999-03-19       Impact factor: 17.367

9.  Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression.

Authors:  J Behr; K Maier; B Degenkolb; F Krombach; C Vogelmeier
Journal:  Am J Respir Crit Care Med       Date:  1997-12       Impact factor: 21.405

Review 10.  Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy.

Authors:  A Gillissen; D Nowak
Journal:  Respir Med       Date:  1998-04       Impact factor: 3.415

View more
  8 in total

1.  In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.

Authors:  A Serrano-Mollar; D Closa; N Prats; S Blesa; M Martinez-Losa; J Cortijo; J M Estrela; E J Morcillo; O Bulbena
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

2.  Endothelial cells recruit macrophages and contribute to a fibrotic milieu in bleomycin lung injury.

Authors:  Heather G Leach; Izabela Chrobak; Rong Han; Maria Trojanowska
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

3.  Effects of leflunomide on inflamation and fibrosis in bleomycine induced pulmonary fibrosis in wistar albino rats.

Authors:  Servet Kayhan; Aygul Guzel; Latif Duran; Serife Tutuncu; Ahmet Guzel; Mithat Gunaydın; Osman Salis; Ali Okuyucu; Mustafa Yasin Selcuk
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

4.  Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis.

Authors:  M Molina-Molina; A Serrano-Mollar; O Bulbena; L Fernandez-Zabalegui; D Closa; A Marin-Arguedas; A Torrego; J Mullol; C Picado; A Xaubet
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

Review 5.  Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases.

Authors:  V L Kinnula
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

6.  Inflammatory monocyte/macrophage modulation by liposome-entrapped spironolactone ameliorates acute lung injury in mice.

Authors:  Wen-Jie Ji; Yong-Qiang Ma; Xin Zhang; Li Zhang; Yi-Dan Zhang; Cheng-Cheng Su; Guo-An Xiang; Mei-Ping Zhang; Zhi-Chun Lin; Lu-Qing Wei; Peizhong P Wang; Zhuoli Zhang; Yu-Ming Li; Xin Zhou
Journal:  Nanomedicine (Lond)       Date:  2016-05-12       Impact factor: 5.307

7.  Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury.

Authors:  J Cortijo; A Iranzo; X Milara; M Mata; M Cerdá-Nicolás; A Ruiz-Saurí; H Tenor; A Hatzelmann; E J Morcillo
Journal:  Br J Pharmacol       Date:  2009-02       Impact factor: 8.739

8.  Roflumilast Prevents the Metabolic Effects of Bleomycin-Induced Fibrosis in a Murine Model.

Authors:  Javier Milara; Esteban Morcillo; Daniel Monleon; Herman Tenor; Julio Cortijo
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.